248 related articles for article (PubMed ID: 16202421)
1. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.
Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A
J Comp Pathol; 2005 Nov; 133(4):246-52. PubMed ID: 16202421
[TBL] [Abstract][Full Text] [Related]
2. [Mammary carcinoma of the female dog: clinical relevance of the immunohistochemical demonstration of micrometastases in the regional lymph nodes].
Busch U; Rudolph R
Tierarztl Prax; 1995 Jun; 23(3):280-6. PubMed ID: 7545833
[TBL] [Abstract][Full Text] [Related]
3. Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis.
Seixas F; Palmeira C; Pires MA; Bento MJ; Lopes C
Vet J; 2011 Jan; 187(1):65-71. PubMed ID: 19955006
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas.
Rasotto R; Zappulli V; Castagnaro M; Goldschmidt MH
Vet Pathol; 2012 Mar; 49(2):330-40. PubMed ID: 21670194
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).
McNiel EA; Ogilvie GK; Powers BE; Hutchison JM; Salman MD; Withrow SJ
J Am Vet Med Assoc; 1997 Dec; 211(11):1422-7. PubMed ID: 9394893
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
8. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis, classification and grading of canine mammary tumours as a model to study human breast cancer: an Clinico-Cytohistopathological study with environmental factors influencing public health and medicine.
Shafiee R; Javanbakht J; Atyabi N; Kheradmand P; Kheradmand D; Bahrami A; Daraei H; Khadivar F
Cancer Cell Int; 2013; 13():79. PubMed ID: 23937693
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
[TBL] [Abstract][Full Text] [Related]
12. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
13. [Mammary carcinoma in female dogs: a new routine diagnosis by the detection of occult micrometastases in the regional lymph nodes].
Busch U; Rudolph R
Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):43-6. PubMed ID: 7786275
[TBL] [Abstract][Full Text] [Related]
14. Canine Mammary Tumors: Comparison of Classification and Grading Methods in a Survival Study.
Canadas A; França M; Pereira C; Vilaça R; Vilhena H; Tinoco F; Silva MJ; Ribeiro J; Medeiros R; Oliveira P; Dias-Pereira P; Santos M
Vet Pathol; 2019 Mar; 56(2):208-219. PubMed ID: 30381007
[TBL] [Abstract][Full Text] [Related]
15. Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.
Vacher-Lavenu MC; Le Tourneau A; Duvillard P; Godefroy N; Pinel MC
Bull Cancer; 1993 Feb; 80(2):135-41. PubMed ID: 8173164
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of regional lymph node status in canine mammary carcinomas.
Szczubiał M; Łopuszynski W
Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
[TBL] [Abstract][Full Text] [Related]
17. RAD51 protein expression is increased in canine mammary carcinomas.
Klopfleisch R; Schütze M; Gruber AD
Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
[TBL] [Abstract][Full Text] [Related]
18. Mammary cancer in the dog: a study of 120 cases.
Mulligan RM
Am J Vet Res; 1975 Sep; 36(9):1391-6. PubMed ID: 169716
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
20. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
